Three-dimensional spheroids as in vitro preclinical models for cancer research

B Pinto, AC Henriques, PMA Silva, H Bousbaa - Pharmaceutics, 2020 - mdpi.com
Most cancer biologists still rely on conventional two-dimensional (2D) monolayer culture
techniques to test in vitro anti-tumor drugs prior to in vivo testing. However, the vast majority …

Three-Dimensional Cell Culture: A Breakthrough in Vivo

D Antoni, H Burckel, E Josset, G Noel - International journal of molecular …, 2015 - mdpi.com
Cell culture is an important tool for biological research. Two-dimensional cell culture has
been used for some time now, but growing cells in flat layers on plastic surfaces does not …

[HTML][HTML] Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy

S Fu, G Li, W Zang, X Zhou, K Shi, Y Zhai - Acta Pharmaceutica Sinica B, 2022 - Elsevier
Nanoparticulate drug delivery systems (Nano-DDSs) have emerged as possible solution to
the obstacles of anticancer drug delivery. However, the clinical outcomes and translation are …

The production of 3D tumor spheroids for cancer drug discovery

S Sant, PA Johnston - Drug Discovery Today: Technologies, 2017 - Elsevier
New cancer drug approval rates are≤ 5% despite significant investments in cancer
research, drug discovery and development. One strategy to improve the rate of success of …

Three-dimensional culture system of cancer cells combined with biomaterials for drug screening

T Nii, K Makino, Y Tabata - Cancers, 2020 - mdpi.com
Simple Summary For the research and development of drug discovery, it is of prime
importance to construct the three-dimensional (3D) tissue models in vitro. To this end, the …

Three-dimensional cell culture: the missing link in drug discovery

S Breslin, L O'Driscoll - Drug discovery today, 2013 - Elsevier
Cells, grown as monolayers (2D models), are routinely used as initial model systems for
evaluating the effectiveness and safety of libraries of molecules with potential as therapeutic …

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

YS DeRose, G Wang, YC Lin, PS Bernard, SS Buys… - Nature medicine, 2011 - nature.com
Abstract Development and preclinical testing of new cancer therapies is limited by the
scarcity of in vivo models that authentically reproduce tumor growth and metastatic …

Recent advances on cell culture platforms for in vitro drug screening and cell therapies: from conventional to microfluidic strategies

BD Cardoso, EMS Castanheira… - Advanced …, 2023 - Wiley Online Library
The clinical translations of drugs and nanomedicines depend on coherent pharmaceutical
research based on biologically accurate screening approaches. Since establishing the 2D in …

Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model

Z Huang, P Yu, J Tang - OncoTargets and therapy, 2020 - Taylor & Francis
Background: The tumor three-dimensional (3D) spheroid model in vitro is effective on
detecting malignant cells and tumorigenesis, and assessing drug resistance. Compared with …

Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides

S Dissanayake, WA Denny, S Gamage… - Journal of Controlled …, 2017 - Elsevier
Efficient intracellular trafficking and targeted delivery to the site of action are essential to
overcome the current drawbacks of cancer therapeutics. Cell Penetrating Peptides (CPPs) …